AI-powered medicinal chemistry platform that accelerates drug design through synthesis-aware generative chemistry and retrosynthesis.
AI-powered platforms that accelerate pharmaceutical drug discovery through molecular simulation, target identification, and compound screening.
AI-powered medicinal chemistry platform that accelerates drug design through synthesis-aware generative chemistry and retrosynthesis.
BenchSci provides an AI platform that helps scientists find published antibody data to improve experiment design and reduce reagent waste.
DeepMind's AI system predicting protein structures with unprecedented accuracy for scientific research.
Multi-omics data platform delivering computational biology and biomarker discovery for oncology drug development.
AI platform for drug discovery using generative AI to design novel molecular structures for clinical development.
Pharmacovigilance and drug safety services platform.
AI drug discovery platform using deep learning to design novel small molecule therapeutics.
AI platform for biologics discovery combining foundation models and experimental biology.
Quantum algorithms startup building drug discovery and life sciences applications for near-term devices.
Biosimulation software and regulatory writing company supporting drug discovery, development, and approval.
AI-powered small molecule drug discovery platform accelerating lead optimization.
AI-powered simulated cell platform for precision oncology that models cancer cell behavior to identify drug targets and biomarkers.
Computational chemistry software for drug discovery.
Drug discovery data management platform for medicinal chemistry and biology teams.
Modeling and simulation software for pharmaceutical drug discovery and development.
Healthcare life sciences company formed by Seven Bridges, Pierian, and UgenTec offering clinical genomics solutions.
AI-ready biomedical data platform that curates multiomics datasets for drug discovery and translational research.
Quantum software platform Forge offering enterprise algorithms for finance, chemistry, and optimization.
Computational drug discovery software and materials science platform.
AI-powered biomedical research platform extracting causal relationships from scientific literature for pharma.
Cheminformatics platform for chemical structure-based registration, search, and prediction in life science R&D.
AI-driven digital pathology software for quantitative tissue analysis used in clinical labs and pharma research.
Enterprise software for biopharma R&D informatics.
AI drug discovery platform using deep learning for structure-based drug design and virtual screening.
AI platform for drug discovery and diagnostics using federated learning on hospital data networks.
Cloud-based platform delivering ELN, chemistry registration, inventory, and LIMS for research organizations.
AI platform for drug discovery with clinical trial optimization
Generative AI platform for de novo drug design that accelerates medicinal chemistry projects.
AI-driven pharma company that designed the first AI-discovered drug to enter clinical trials using precision engineering of molecules.
AI-powered rare disease drug discovery platform that identifies treatments for rare diseases using knowledge graphs and deep learning.
AI-powered drug discovery company combining physics-based simulation with deep learning to accelerate small molecule drug development.
AI-powered protein engineering platform that uses machine learning and automated experiments to discover next-generation antibodies.
Drug discovery company from Alphabet using AlphaFold-derived AI technology to understand biological systems and design medicines.
AI-powered pharmaceutical technology company using quantum physics and AI for crystal structure prediction and drug formulation.
Drug discovery and development company using AI platforms for target identification, compound design, and clinical development.
Drug discovery company using AI and motion-based biochemistry to design precision medicines targeting protein motion dynamics.
Origin Bio is a YC W26 company that built a DNA model outperforming DeepMind's AlphaGenome, focusing on genomics AI research.
AI-powered antibody discovery company using deep learning to design therapeutic antibodies against challenging drug targets.
Generative biology company using AI to design novel protein therapeutics including antibodies and enzymes for medicine.
Generative AI drug and target discovery company using deep learning to design next-generation antibody therapeutics.
Recursion-owned AI drug discovery research lab building foundational models for chemistry and biology.
AI drug discovery platform integrating biology and chemistry.
Technology-driven drug discovery and development platform.
AI platform for RNA therapeutic drug discovery.